Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital.
The number of ampicillin-resistant enterococci (ARE) was noted to be increased at our teaching hospital.
To determine the risk factors for acquiring this organism and to compare clinical outcomes, over a 5-month period 38 patients infected or colonized with ARE were compared with 76 patients infected or colonized with ampicillin-susceptible enterococci (ASE).
Risk factors included nosocomial acquisition, duration of hospitalization, admission to a medical service, prior antimicrobial therapy, and combination therapy for at least 7 days.
The mortality rate of patients infected or colonized with ARE was higher than that of patients infected or colonized with ASE (34 versus 14% ; P=0.03), but most deaths did not appear to be related to enterococcal infection.
Mots-clés Pascal : Enterococcus, Streptococcaceae, Micrococcales, Bactérie, Homme, Facteur risque, Résistance, Ampicilline, Antibiotique, Antibactérien, Hôpital, Canada, Amérique du Nord, Amérique, Bactériémie, Bactériose, Infection, Infection nosocomiale
Mots-clés Pascal anglais : Enterococcus, Streptococcaceae, Micrococcales, Bacteria, Human, Risk factor, Resistance, Antibiotic, Antibacterial agent, Hospital, Canada, North America, America, Bacteremia, Bacteriosis, Infection, Nosocomial infection
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0012203
Code Inist : 002B05B02P. Création : 09/06/1995.